Named on one round in the feed.
Since 2026-06-15
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Cellares Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers. | Series D Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2026-06-15 | [ PART ] |